Abstract:Key PointsThe molecular mechanism of activation for a representative effector caspase, caspase-7, is revealed by the conformational changes of the active site that take place after the activation cleavage. The essence of this mechanism is the provision of the L2′ loop, which is released by the activation cleavage and provides crucial support for the conformation of the active site.The molecular mechanism of inhibitor of apoptosis (IAP)-mediated inhibition of an effector caspase primarily involves the occupation of the caspase active site by an extended peptide fragment that immediately precedes the second baculoviral IAP repeat (BIR) domain, BIR2, of XIAP, c-IAP1 or c-IAP2.The BIR3 domain of XIAP inhibits caspase-9, an initiator caspase, by sequestering caspase-9 in a monomeric state, so that the L2′ loop cannot be provided by the adjacent monomer and the active site cannot be productively formed. This inhibition is dependent on, and initiated by, the binding between a conserved surface groove of the BIR3 domain of XIAP and the N-terminal tetrapeptide (Ala-Thr-Pro-Phe) of the small subunit of caspase-9.The viral protein p35 inhibits a caspase through the formation of a covalent thioester bond between the catalytic residue Cys360 of caspase-8 and Asp87 of p35, which follows caspase-mediated cleavage of the reactive-site loop of p35 after Asp87.The XIAP-mediated inhibition of caspase-9 can be countered effectively by SMAC/DIABLO, which uses its N-terminal tetrapeptide (Ala-Val-Pro-Ile) to compete with caspase-9 for binding to the same conserved surface groove of the BIR3 domain of XIAP. In Drosophila melanogaster, the caspase-9 orthologue Dronc is suppressed by Diap1 through an interaction that involves an internal peptide fragment of Dronc and the conserved surface groove of the BIR2 domain of Diap1. The pro-apoptotic proteins Reaper, Hid, Grim and Sickle use their N-terminal peptide fragments (which are similar to the SMAC/DIABLO tetrapeptide) to compete with Dronc for binding to the same conserved surface groove, thereby removing the Diap1-mediated negative regulation of Dronc.The exact mechanisms for the removal of effector-caspase inhibition remain to be defined. The prevailing model, which is supported by biochemical data, is that the binding of effector caspases by SMAC/DIABLO creates steric hindrance that dissociates the interaction between IAPs and the effector caspases.To gain a comprehensive picture of the molecular mechanisms of caspase regulation, future efforts should be directed at understanding the activation of initiator caspases and caspase pathways in Drosophila melanogaster and Caenorhabditis elegans.

Molecular Determinants of the Caspase-Promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway.

Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein

Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells

Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation

Molecular mechanisms of caspase regulation during apoptosis

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.

Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression

Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps

BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis

Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.

BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites

Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines

IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation

Caspase-9-Induced Mitochondrial Disruption Through Cleavage Of Anti-Apoptotic Bcl-2 Family Members

Mitochondria Localization and Dimerization Are Required for CIDE-B to Induce Apoptosis

Design, in silico evaluation, and in vitro verification of new bivalent Smac mimetics with pro-apoptotic activity

Targeting caspase-8/c-FLIPL heterodimer in complex II promotes DL-mediated cell death

Siva-1 and an Alternative Splice Form Lacking the Death Domain, Siva-2, Similarly Induce Apoptosis in T Lymphocytes via a Caspase-Dependent Mitochondrial Pathway

Structural basis for regulation of apoptosis and autophagy by the BIRC6/SMAC complex